Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Telemedicine Strategy With Home Treatment Save Resources

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02214017
Recruitment Status : Completed
First Posted : August 12, 2014
Results First Posted : November 19, 2018
Last Update Posted : November 19, 2018
Sponsor:
Information provided by (Responsible Party):
Ole Winther Rasmussen, Kolding Sygehus

Brief Summary:

Progress in technology has made telemedicine-based solutions with video consultations available in the management and treatment of chronic diseases like diabetes, heart failure and lung insufficiency at home. However, no direct comparisons on health outcomes of telemedicine using video consultations versus usual outpatient treatment are available.

We wanted to implement a model of telemedicine and to evaluate health indicators in type 2 diabetes patients treated by video consultations or the standard outpatient treatment


Condition or disease Intervention/treatment Phase
Type 2 Diabetes Mellitus Device: A videotelephone, TandBerg E20, Behavioral: Behavioral motivation Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Can a Telemedicine Strategy With Home Treatment Save Resources in Acute Medical Conditions While Maintaining Quality of Care?
Study Start Date : October 2011
Actual Primary Completion Date : July 2012
Actual Study Completion Date : October 2012

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Standard care
Diabetic patients attended usual procedure in the outpatient clinic with regular visits
Behavioral: Behavioral motivation
Optimization of medical care in diabetes

Experimental: Telemedicine group
After initial check-up in the outpatient dept. medical treatment, control of blood glucose, blood pressure, lipids, and education was executed via videotelephone in the telemedicine group. A videotelephone, TandBerg E20, in the telemedicine group was delivered and serviced by the Danish Tele Company, TDC.
Device: A videotelephone, TandBerg E20,
Behavioral: Behavioral motivation
Optimization of medical care in diabetes




Primary Outcome Measures :
  1. Glycemia [ Time Frame: Six months of treatment ]
    Percent of glycosylated hemoglobin, HbA1c


Secondary Outcome Measures :
  1. Lipids [ Time Frame: Six months of treatment ]
    Total-cholesterol


Other Outcome Measures:
  1. Blood Pressure [ Time Frame: Six months of treatment ]
    Diurnal blood pressure measured by Spacelab monitor, Spacelab 90207



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

The participants had to live at home, be able to communicate by videotelephone, had no psychiatric disorders, an age between 40 and 85 years and be able to administer medication. -

Exclusion Criteria:

Exclusion criteria were type 1 diabetes, speech disabilities, non-Danish speakers or with severe chronic disease like renal failure (GFR<30 ml/min), liver insufficiency or in cancer treatment.

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02214017


Locations
Layout table for location information
Denmark
Endrinology Dept, Kolding Hospital
Kolding, Denmark, 6000
Sponsors and Collaborators
Kolding Sygehus
Investigators
Layout table for investigator information
Principal Investigator: Ole W Rasmussen, Dr.Med.Scie Kolding Sygehus

Study Data/Documents: publication  This link exits the ClinicalTrials.gov site
Identifier: doi: 10.1177/1357633X15608984

Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Ole Winther Rasmussen, Senior Consultant, Associate Professor, Kolding Sygehus
ClinicalTrials.gov Identifier: NCT02214017     History of Changes
Other Study ID Numbers: Telemedicine in type 2 DM
First Posted: August 12, 2014    Key Record Dates
Results First Posted: November 19, 2018
Last Update Posted: November 19, 2018
Last Verified: November 2018

Keywords provided by Ole Winther Rasmussen, Kolding Sygehus:
diabetes
telemedicine
glycemia
lipids
blood pressure

Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases